Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Alios BioPharma brings in $8.4mm with first close of Series A

Executive Summary

Alios BioPharma (small-molecule and protein therapeutics for viral diseases) has pulled in $8.4mm through the first tranche of its Series A financing of preferred shares. Lead investors Novo Ventures and Novartis Ventures were joined by Roche Venture Fund. The company could raise a total of $24mm in the round.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies